Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

NCT00304993 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome X
Insulin Resistance

Interventions

DRUG: fenofibrate
DRUG: niacin
DRUG: rosiglitazone

Sponsor

Foundation Research, Florida

Collaborators

[object Object]
[object Object]
[object Object]